Philippines - English - FDA (Food And Drug Administration)

oxford distributions, inc. - multivitamins , amino acids - forte capsule - [see reverse for formulation]

Philippines - English - FDA (Food And Drug Administration)

oxford distributions, inc. - phenylpropanolamine hydrochloride - syrup - 12.5 mg/ 5ml

Philippines - English - FDA (Food And Drug Administration)

oxford distributions, inc. - phenylpropanolamine hydrochloride / chlorphenamine maleate - syrup - 12.5mg/2mg/5ml

Philippines - English - FDA (Food And Drug Administration)

oxford distributions, inc. - phenylpropanolamine hydrochloride , paracetamol - capsule - 25 mg/ 325 mg

Philippines - English - FDA (Food And Drug Administration)

oxford distributions, inc. - phenylpropanolamine hydrochloride - syrup - 12.5mg/5ml

Philippines - English - FDA (Food And Drug Administration)

oxford distributions, inc. - paracetamol , phenylpropanolamine hydrochloride - syrup - 250mg/12.5mg/5ml

United States - English - NLM (National Library of Medicine)

oxford pharmaceuticals, llc - primidone (unii: 13afd7670q) (primidone - unii:13afd7670q) - primidone, used alone or concomitantly with other anticonvulsants, is indicated in the control of grand mal, psychomotor, and focal epileptic seizures. it may control grand mal seizures refractory to other anticonvulsant therapy. primidone is contraindicated in: 1) patients with porphyria and 2) patients who are hypersensitive to phenobarbital (see actions ).

United States - English - NLM (National Library of Medicine)

oxford pharmaceuticals, llc - paroxetine hydrochloride (unii: x2els050d8) (paroxetine - unii:41vrh5220h) - paroxetine is indicated in adults for the treatment of: - major depressive disorder (mdd) - obsessive compulsive disorder (ocd) - panic disorder (pd) - social anxiety disorder (sad) - generalized anxiety disorder (gad) - posttraumatic stress disorder (ptsd) paroxetine is contraindicated in patients: - taking, or within 14 days of stopping, maois (including the maois linezolid and intravenous methylene blue) because of an increased risk of serotonin syndrome [see warnings and precautions (5.2), drug interactions ( 7)]. - taking thioridazine because of risk of qt prolongation [see warnings and precautions (5.3) and drug interactions (7)]. - t aking pimozide because of risk of qt prolongation[see warnings and precautions (5.3), drug interactions (7)]. - with known hypersensitivity (e.g., anaphylaxis, angioedema, stevens-johnson syndrome) to paroxetine or any of the inactive ingredients in paroxetine tablets, usp[see adverse reactions (6.1), (6.2)] . pregnancy category d [see warnings and precautions (5.4)]

Australia - English - Department of Health (Therapeutic Goods Administration)

zimmer biomet pty ltd - 34195 - unicondylar knee prosthesis - a partial knee system to be used in patients with anteromedial osteoarthritis or avascular necrosis. the device consists of a spherical design femoral bearing surface with a fully mobile bearing that stays congruent with the femoral component throughout the entire range of motion. the tibial tray is anatomically shaped and has a highly polished surface for the bearing to articulate on. the bearing is intended to be imlanted without the use of bone cement. the cementless oxford partial knee is intended for use in individuals with osteoarthritis or avascular necorosis limited to the medial compartment of the knee and is intended to be implanted without the application of bone cement.

Australia - English - Department of Health (Therapeutic Goods Administration)

zimmer biomet pty ltd - 34195 - unicondylar knee prosthesis - the tibial component of a partial knee. the tray is anatomically shaped and has a highly polished surface for the bearing to articulate on. the keel is modified to include an extractor slot the oxford partial knee is intended for use in individuals with osteoarthritis or avascular necrosis limited to the medial compartment of the knee and is intended to be implanted with bone cement.